Arena BioWorks, an ambitious biomedical institute backed by billionaires, abruptly shuts down www.statnews.com/2025/11/04/a... via @statnews.com
Arena BioWorks, an ambitious biomedical institute backed by billionaires, abruptly shuts down
Exclusive: Arena Bioworks, the buzzy research institute that launched with $500 million to support a decade of scientific R&D, is abruptly shutting down, STAT has learned.
www.statnews.com
November 5, 2025 at 5:24 AM
Arena BioWorks, an ambitious biomedical institute backed by billionaires, abruptly shuts down www.statnews.com/2025/11/04/a... via @statnews.com
In @elife.bsky.social: Blocking Osteoprotegerin Reprograms Cancer Associated Fibroblast to Promotes Immune Infiltration into the Tumor Microenvironment doi.org/10.7554/eLif...
Blocking Osteoprotegerin Reprograms Cancer Associated Fibroblast to Promotes Immune Infiltration into the Tumor Microenvironment
doi.org
October 17, 2025 at 10:14 PM
In @elife.bsky.social: Blocking Osteoprotegerin Reprograms Cancer Associated Fibroblast to Promotes Immune Infiltration into the Tumor Microenvironment doi.org/10.7554/eLif...
The “valley of death” is getting increasingly treacherous with NIH in shambles and VCs increasingly training their money at clinical stage companies.
October 14, 2025 at 4:00 PM
The “valley of death” is getting increasingly treacherous with NIH in shambles and VCs increasingly training their money at clinical stage companies.
Another one bites the dust. www.fiercebiotech.com/biotech/novo...
Novo shutters cell therapy unit, ending work on potential Type 1 diabetes 'cure'
Novo Nordisk is ending all work in cell therapy, including a Type 1 diabetes program, amid CEO Maziar Mike Doustdar's reorganization. | Novo Nordisk is ending all work in cell therapy, including a Typ...
www.fiercebiotech.com
October 11, 2025 at 12:08 AM
Another one bites the dust. www.fiercebiotech.com/biotech/novo...
www.magd.cam.ac.uk
October 8, 2025 at 1:32 AM
It’s another blow to a cell therapy industry that has fallen out of favor as companies struggled to develop next-generation cell therapies that were both effective and could make the complex and expensive treatments more widely accessible. endpoints.news/takeda-stops...
Takeda stops all work in cell therapy
Takeda's decision is another blow to a cell therapy industry that has fallen out of favor.
endpoints.news
October 1, 2025 at 3:53 PM
It’s another blow to a cell therapy industry that has fallen out of favor as companies struggled to develop next-generation cell therapies that were both effective and could make the complex and expensive treatments more widely accessible. endpoints.news/takeda-stops...
Doesnt bode well for muscle preservation combo approach. www.reuters.com/business/hea...
Eli Lilly halts trial testing experimental muscle-preserving drug with Zepbound
Eli Lilly has halted a study of an experimental drug, designed to prevent obesity patients from losing too much muscle, due to strategic business reasons, according to a U.S. registry of clinical trials.
www.reuters.com
September 26, 2025 at 4:55 PM
Doesnt bode well for muscle preservation combo approach. www.reuters.com/business/hea...
September 18, 2025 at 7:27 AM
What a phenomenal retrospective at SFMOMA
September 2, 2025 at 12:23 AM
What a phenomenal retrospective at SFMOMA
iPSCs are generated by reprogramming adult cells into a pluripotent state, similar to embryonic stem cells, but with the advantage of being derived from the patient's own cells, reducing the risk of immune rejection.
What is the evidence this is true?
What is the evidence this is true?
August 18, 2025 at 12:19 AM
iPSCs are generated by reprogramming adult cells into a pluripotent state, similar to embryonic stem cells, but with the advantage of being derived from the patient's own cells, reducing the risk of immune rejection.
What is the evidence this is true?
What is the evidence this is true?
Trump executive order seeks to centralize control of grantmaking under political appointees www.statnews.com/2025/08/08/t... via @statnews.com
Trump executive order seeks to centralize control of grantmaking under political appointees
A sweeping new executive order seeks to transform how the federal government awards billions of dollars in research grants
www.statnews.com
August 8, 2025 at 5:06 PM
Trump executive order seeks to centralize control of grantmaking under political appointees www.statnews.com/2025/08/08/t... via @statnews.com
Senate Appropriations Committee retained all 27 NIH institutes and centers, rejecting a White House consolidation proposal, and rejected the administration’s plan to revamp the way NIH pays universities, medical schools, and other research centers for overhead costs.
July 31, 2025 at 8:11 PM
Senate Appropriations Committee retained all 27 NIH institutes and centers, rejecting a White House consolidation proposal, and rejected the administration’s plan to revamp the way NIH pays universities, medical schools, and other research centers for overhead costs.
PS :Susan Collins Trump administration blocks NIH from awarding any research grants and contracts www.statnews.com/2025/07/29/t... via @statnews.com
Trump administration blocks NIH from awarding any research grants and contracts
The order applies to the entirety of new and, possibly, ongoing research grant dollars that go to universities and academic medical centers.
www.statnews.com
July 30, 2025 at 3:23 AM
PS :Susan Collins Trump administration blocks NIH from awarding any research grants and contracts www.statnews.com/2025/07/29/t... via @statnews.com
NIH is shrinking the number of research projects it funds due to a new Trump policy www.statnews.com/2025/07/29/n... via @statnews.com
NIH is shrinking the number of research projects it funds due to a new Trump policy
NIH plans to shrink the share of grant applications it will award for the remainder of the fiscal year, in some cases by more than half.
www.statnews.com
July 29, 2025 at 4:44 PM
NIH is shrinking the number of research projects it funds due to a new Trump policy www.statnews.com/2025/07/29/n... via @statnews.com
misguided on so many levels
grants.nih.gov/news-events/...
grants.nih.gov/news-events/...
NIH Funding Announcements to Align with NIH Initiative to Prioritize Human-based Research | Grants & Funding
grants.nih.gov
July 24, 2025 at 7:41 PM
misguided on so many levels
grants.nih.gov/news-events/...
grants.nih.gov/news-events/...
Reposted by BhushanLab
Congrats to Anil Bhushan @bhushanlab.bsky.social and Gregory Ku for receiving a 2025 Beatson Foundation Award for their projects "Targeting Pancreatic Stromal Cells to Halt T1D," and "Using Massively Parallel Monitoring of Insulin Secretion to Make a Better Stem cell-Derived β Cell," respectively.
July 11, 2025 at 7:00 PM
Congrats to Anil Bhushan @bhushanlab.bsky.social and Gregory Ku for receiving a 2025 Beatson Foundation Award for their projects "Targeting Pancreatic Stromal Cells to Halt T1D," and "Using Massively Parallel Monitoring of Insulin Secretion to Make a Better Stem cell-Derived β Cell," respectively.
It is increasingly recognized that immunosuppressive barriers within the tumor microenvironment present a major obstacle to the efficacy of checkpoint inhibitors and adoptive T cell therapies in patients with solid tumors.
July 8, 2025 at 6:20 AM
It is increasingly recognized that immunosuppressive barriers within the tumor microenvironment present a major obstacle to the efficacy of checkpoint inhibitors and adoptive T cell therapies in patients with solid tumors.
Biomea joins the GLP1 bandwagon-what happened to the Menin inhibitor-a pivot or just changing subject?
investors.biomeafusion.com/news-release...
investors.biomeafusion.com/news-release...
investors.biomeafusion.com
June 18, 2025 at 9:19 PM
Biomea joins the GLP1 bandwagon-what happened to the Menin inhibitor-a pivot or just changing subject?
investors.biomeafusion.com/news-release...
investors.biomeafusion.com/news-release...
Cells in a bag don’t work. The focus is now on immune suppression ftp.fiercehealthpayersummit.com/biotech/vert...
Vertex lays off 125 staffers, slims Rhode Island campus after ditching failed diabetes cell-device combo
Vertex is trimming its Rhode Island footprint on the back of a scrapped “cells plus device” program in diabetes, leaving 125 staffers out of a job. | The company is merging its three buildings at its ...
ftp.fiercehealthpayersummit.com
June 15, 2025 at 7:11 PM
Cells in a bag don’t work. The focus is now on immune suppression ftp.fiercehealthpayersummit.com/biotech/vert...
California state film tax credit doubled while money for scientific research SB 829, an investment that creates new jobs is rejected by senate appropriations. Where is the California that invents the future.
June 6, 2025 at 7:21 PM
California state film tax credit doubled while money for scientific research SB 829, an investment that creates new jobs is rejected by senate appropriations. Where is the California that invents the future.
Taurine, a darling of longevity seekers, is found to be unreliable biomarker for aging www.statnews.com/2025/06/05/t... via @statnews.com
Taurine, a darling of longevity seekers, is found to be unreliable biomarker for aging
A study shows levels of the amino acid taurine rise rather than fall over time, confounding the goal of dietary supplements popular in anti-aging circles.
www.statnews.com
June 6, 2025 at 2:34 AM
Taurine, a darling of longevity seekers, is found to be unreliable biomarker for aging www.statnews.com/2025/06/05/t... via @statnews.com
Sebastião Salgado, Acclaimed Brazilian Photographer, Is Dead at 81 www.nytimes.com/2025/05/23/a...
Sebastião Salgado, Acclaimed Brazilian Photographer, Is Dead at 81
www.nytimes.com
May 24, 2025 at 4:29 AM
Sebastião Salgado, Acclaimed Brazilian Photographer, Is Dead at 81 www.nytimes.com/2025/05/23/a...
The reprogramming arms race-is it good for biotech?
Longevity startup Retro Biosciences working on personalized blood disorders seeks $1b in funds.
Retro Biosciences inks blood disorder deal as Sam Altman-backed biotech seeks $1B in funds
A longevity startup called Retro Biosciences is working on personalized blood disorder therapies thanks to a partnership with the Murdoch Children's Research Institute in Australia. The California bio...
endpts.com
May 20, 2025 at 6:13 PM
The reprogramming arms race-is it good for biotech?